Martha A, Strong L C, Ferrell R E, Saunders G F
Department of Biochemistry and Molecular Biology, University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA.
Hum Mutat. 1995;6(1):44-9. doi: 10.1002/humu.1380060109.
Aniridia (iris hypoplasia) is an autosomal dominant congenital disorder of the eye. Mutations in the human aniridia (PAX6) gene have now been identified in many patients from various ethnic groups. In the study reported here we describe PAX6 mutations in one sporadic and five familial cases with aniridia. Of the four different mutations identified, one was identical to a previously reported mutation (C-->T transition at codon 240), and three were novel: two in the glycine-rich region and one in the proline/serine/threonine-rich (PST) region. One PAX6 mutation found in the PST region was associated with cataracts in an aniridia family. Another splice mutation in the PST domain occurred in an aniridia patient with anosmia (inability to smell). The six new aniridia cases reported here have mutations predicted to generate incomplete PAX6 proteins. These results support the theory that human aniridia is caused by haploinsufficiency of PAX6.
无虹膜症(虹膜发育不全)是一种常染色体显性遗传的先天性眼部疾病。目前已在来自不同种族的许多患者中发现了人类无虹膜症(PAX6)基因的突变。在本文报道的研究中,我们描述了1例散发型和5例家族型无虹膜症病例中的PAX6突变。在鉴定出的4种不同突变中,1种与先前报道的突变相同(密码子240处的C→T转换),另外3种是新发现的:2种位于富含甘氨酸区域,1种位于富含脯氨酸/丝氨酸/苏氨酸(PST)区域。在一个无虹膜症家族中,在PST区域发现的一种PAX6突变与白内障有关。在一名患有嗅觉缺失(无法嗅觉)的无虹膜症患者中发生了PST结构域的另一种剪接突变。本文报道的6例新的无虹膜症病例具有预测会产生不完整PAX6蛋白的突变。这些结果支持了人类无虹膜症是由PAX6单倍剂量不足引起的这一理论。